Interplay between receptor tyrosine kinases and hypoxia signaling in cancer

International Journal of Biochemistry and Cell Biology

Volumn 62, Issue , 2015, Pages 101-114

  Glück, Astrid A ^a   Aebersold, Daniel M ^a   Zimmer, Yitzhak ^a   Medová, Michaela ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cancer; HIF system; Hypoxia; RTKs; VEGF

Indexed keywords

AXL RECEPTOR TYROSINE KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR; PROTEIN TYROSINE KINASE; RON RECEPTOR TYROSINE KINASE; SCATTER FACTOR RECEPTOR; SOMATOMEDIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1;

BINDING SITE; CANCER CONTROL; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESISTANCE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HYPOXIA; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGEN TENSION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANOXIA; CELL HYPOXIA; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANOXIA; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84925625767     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.02.018     Document Type: Review

References (193)

1. O. Abdel-Rahman Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: preclinical and clinical aspects Crit Rev Oncol Hematol 93 1 2015 18 27
2. M.J. Abedin, D. Wang, M.A. McDonnell, U. Lehmann, and A. Kelekar Autophagy delays apoptotic death in breast cancer cells following DNA damage Cell Death Differ 14 3 2007 500 510
3. I. Ader, C. Delmas, N. Skuli, F. Darlot, G. Favre, and F. Bono In vitro and in vivo radiosensitization by FGFR-1 inhibition using the antagonist SSR128129E in human glioblastoma models Neuro-Oncology 12 Suppl. 4 2010
4. I. Ader, C. Delmas, N. Skuli, J. Bonnet, P. Schaeffer, and F. Bono Preclinical evidence that SSR128129E - a novel small-molecule multi-fibroblast growth factor receptor blocker - radiosensitises human glioblastoma Eur J Cancer 50 13 2014 2351 2359
5. C.L. Arteaga, and J.A. Engelman ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics Cancer Cell 25 3 2014 282 303
6. R. Bagheri-Yarmand, R.K. Vadlamudi, R.A. Wang, J. Mendelsohn, and R. Kumar Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis J Biol Chem 275 50 2000 39451 39457
7. K. Beppu, K. Nakamura, W.M. Linehan, A. Rapisarda, and C.J. Thiele Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells Cancer Res 65 11 2005 4775 4781
8. V.A. Blakesley, A. Scrimgeour, D. Esposito, and D. Le Roith Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? Cytokine Growth Factor Rev 7 2 1996 153 159
9. C. Blick, A. Ramachandran, S. Wigfield, R. McCormick, A. Jubb, and F.M. Buffa Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer Br J Cancer 109 1 2013 50 59
10. C. Boccaccio, and P.M. Comoglio Invasive growth: a MET-driven genetic programme for cancer and stem cells Nat Rev Cancer 6 8 2006 637 645
11. F. Bontemps, M.F. Vincent, and G. Van den Berghe Mechanisms of elevation of adenosine levels in anoxic hepatocytes Biochem J 290 Pt 3 1993 671 677
12. B. Boursi, K. Haynes, R. Mamtani, and Y.X. Yang Digoxin use and the risk for colorectal cancer Pharmacoepidemiol Drug Saf 23 11 2014 1147 1153
13. E.C. Brantley, L.B. Nabors, G.Y. Gillespie, Y.H. Choi, C.A. Palmer, and K. Harrison Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression Clin Cancer Res 14 15 2008 4694 4704
14. C. Bucci, R.G. Parton, I.H. Mather, H. Stunnenberg, K. Simons, and B. Hoflack The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway Cell 70 5 1992 715 728
15. I.M. Buchanan, T. Scott, A.T. Tandle, W.E. Burgan, T.L. Burgess, and P.J. Tofilon Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody: AMG102 J Cell Mol Med 15 9 2011 1999 2006
16. F.M. Buffa, C. Camps, L. Winchester, C.E. Snell, H.E. Gee, and H. Sheldon microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer Cancer Res 71 17 2011 5635 5645
17. H.F. Bunn, and R.O. Poyton Oxygen sensing and molecular adaptation to hypoxia Physiol Rev 76 3 1996 839 885
18. S. Buraschi, N. Pal, N. Tyler-Rubinstein, R.T. Owens, T. Neill, and R.V. Iozzo Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels J Biol Chem 285 53 2010 42075 42085
19. M. Calvani, A. Rapisarda, B. Uranchimeg, R.H. Shoemaker, and G. Melillo Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells Blood 107 7 2006 2705 2712
20. M.T. Canning, L.M. Postovit, S.H. Clarke, and C.H. Graham Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells Exp Cell Res 267 1 2001 88 94
21. P. Carmeliet, Y. Dor, J.M. Herbert, D. Fukumura, K. Brusselmans, and M. Dewerchin Role of HIF-1alpha in hypoxia-mediated apoptosis: cell proliferation and tumour angiogenesis Nature 394 6692 1998 485 490
22. J.B. Casaletto, and A.I. McClatchey Spatial regulation of receptor tyrosine kinases in development and cancer Nat Rev Cancer 12 6 2012 387 400
23. J.W. Catto, S. Miah, H.C. Owen, H. Bryant, K. Myers, and E. Dudziec Distinct microRNA alterations characterize high- and low-grade bladder cancer Cancer Res 69 21 2009 8472 8481
24. H.Y. Chang, H.S. Liu, M.D. Lai, Y.S. Tsai, T.S. Tzai, and H.L. Cheng Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON Cancer Res 74 16 2014 4549 4562
25. J.C. Cheng, C. Klausen, and P.C. Leung Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells Cancer Lett 329 2 2013 197 206
26. M.M. Chitnis, J.S. Yuen, A.S. Protheroe, M. Pollak, and V.M. Macaulay The type 1 insulin-like growth factor receptor pathway Clin Cancer Res 14 20 2008 6364 6370
27. Y.J. Choi, J.K. Rho, S.J. Lee, W.S. Jang, S.S. Lee, and C.H. Kim HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines J Cancer Res Clin Oncol 135 8 2009 1047 1053
28. M. Choura, and A. Rebai Receptor tyrosine kinases: from biology to pathology J Recept Signal Transduct Res 31 6 2011 387 394
29. S. Chumsri, T. Howes, T. Bao, G. Sabnis, and A. Brodie Aromatase, aromatase inhibitors, and breast cancer J Steroid Biochem Mol Biol 125 1-2 2011 13 22
30. A.S. Chung, J. Lee, and N. Ferrara Targeting the tumour vasculature: insights from physiological angiogenesis Nat Rev Cancer 10 7 2010 505 514
31. F. Ciardiello, R. Caputo, R. Bianco, V. Damiano, G. Pomatico, and S. Pepe Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide J Natl Cancer Inst 90 14 1998 1087 1094
32. G. Csordas, M. Santra, C.C. Reed, I. Eichstetter, D.J. McQuillan, and D. Gross Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo J Biol Chem 275 42 2000 32879 32887
33. N.A. Dallas, L. Xia, F. Fan, M.J. Gray, P. Gaur, and G. van Buren Chemoresistant colorectal cancer cells: the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition Cancer Res 69 5 2009 1951 1957
34. J.E. Dancey, R. Curiel, and J. Purvis Evaluating temsirolimus activity in multiple tumors: a review of clinical trials Semin Oncol 36 Suppl. 3 2009 S46 S58
35. B. Das, H. Yeger, R. Tsuchida, R. Torkin, M.F. Gee, and P.S. Thorner A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma Cancer Res 65 16 2005 7267 7275
36. C.R. Degnin, M.B. Laederich, and W.A. Horton Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3 Mol Biol Cell 22 20 2011 3861 3873
37. D. Del Bufalo, L. Ciuffreda, D. Trisciuoglio, M. Desideri, F. Cognetti, and G. Zupi Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus Cancer Res 66 11 2006 5549 5554
38. N. Denko, C. Schindler, A. Koong, K. Laderoute, C. Green, and A. Giaccia Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment Clin Cancer Res 6 2 2000 480 487
39. P. Ditte, F. Dequiedt, E. Svastova, A. Hulikova, A. Ohradanova-Repic, and M. Zatovicova Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors Cancer Res 71 24 2011 7558 7567
40. A.M. Dulak, C.T. Gubish, L.P. Stabile, C. Henry, and J.M. Siegfried HGF-independent potentiation of EGFR action by c-Met Oncogene 30 33 2011 3625 3635
41. M. Enguita-Germán, and P. Fortes Targeting the insulin-like growth factor pathway in hepatocellular carcinoma World J Hepatol 6 10 2014 716 737
42. G.S. Falchook, J.J. Wheler, A. Naing, E.F. Jackson, F. Janku, and D. Hong Targeting hypoxia-inducible factor-1alpha (HIF-1alpha) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab Oncotarget 5 21 2014 10280 10292
43. D. Feldser, F. Agani, N.V. Iyer, B. Pak, G. Ferreira, and G.L. Semenza Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2 Cancer Res 59 16 1999 3915 3918
44. N. Ferrara Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications Semin Oncol 29 6 Suppl. 16 2002 10 14
45. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr Rev 18 1 1997 4 25
46. A. Follenzi, S. Bakovic, P. Gual, M.C. Stella, P. Longati, and P.M. Comoglio Cross-talk between the proto-oncogenes Met and Ron Oncogene 19 27 2000 3041 3049
47. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, and R.D. Koos Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol Cell Biol 16 9 1996 4604 4613
48. A. Franovic, L. Gunaratnam, K. Smith, I. Robert, D. Patten, and S. Lee Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer Proc Natl Acad Sci USA 104 32 2007 13092 13097
49. R. Fukuda, K. Hirota, F. Fan, Y.D. Jung, L.M. Ellis, and G.L. Semenza Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression: which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells J Biol Chem 277 41 2002 38205 38211
50. H. Funatsu, H. Yamashita, H. Noma, E. Shimizu, T. Yamashita, and S. Hori Stimulation and inhibition of angiogenesis in diabetic retinopathy Jpn J Ophthalmol 45 6 2001 577 584
51. J. Galle, U. Zabel, U. Hubner, A. Hatzelmann, B. Wagner, and C. Wanner Effects of the soluble guanylyl cyclase activator: YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity Br J Pharmacol 127 1 1999 195 203
52. S.S. Ganapathipillai, M. Medova, D.M. Aebersold, P.W. Manley, S. Berthou, and B. Streit Coupling of mutated met variants to DNA repair via Abl and Rad51 Cancer Res 68 14 2008 5769 5777
53. M.B. Gariboldi, R. Ravizza, and E. Monti The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells Biochem Pharmacol 80 4 2010 455 462
54. E. Gherardi, W. Birchmeier, C. Birchmeier, and G. Vande Woude Targeting MET in cancer: rationale and progress Nat Rev Cancer 12 2 2012 89 103
55. C.H. Graham, T.E. Fitzpatrick, and K.R. McCrae Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway Blood 91 9 1998 3300 3307
56. L. Gunaratnam, M. Morley, A. Franovic, N. de Paulsen, K. Mekhail, and D.A. Parolin Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells J Biol Chem 278 45 2003 44966 44974
57. P. Hamerlik, J.D. Lathia, R. Rasmussen, Q. Wu, J. Bartkova, and M. Lee Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth J Exp Med 209 3 2012 507 520
58. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
59. L.S. Harrington, G.M. Findlay, and R.F. Lamb Restraining PI3K: mTOR signalling goes back to the membrane Trends Biochem Sci 30 1 2005 35 42
60. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 1 2002 38 47
61. L. Holmquist-Mengelbier, E. Fredlund, T. Löfstedt, R. Noguera, S. Navarro, and H. Nilsson Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype Cancer Cell 10 5 2006 413 423
62. T. Ide, Y. Kitajima, A. Miyoshi, T. Ohtsuka, M. Mitsuno, and K. Ohtaka Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway Int J Cancer 119 12 2006 2750 2759
63. E. Ikeda, M.G. Achen, G. Breier, and W. Risau Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells J Biol Chem 270 34 1995 19761 19766
64. O. Iliopoulos, A. Kibel, S. Gray, and W.G. Kaelin Tumour suppression by the human von Hippel-Lindau gene product Nat Med 1 8 1995 822 826
65. R.V. Iozzo, D.K. Moscatello, D.J. McQuillan, and I. Eichstetter Decorin is a biological ligand for the epidermal growth factor receptor J Biol Chem 274 8 1999 4489 4492
66. B.H. Jiang, J.Z. Zheng, S.W. Leung, R. Roe, and G.L. Semenza Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension J Biol Chem 272 31 1997 19253 19260
67. B.H. Jiang, G. Jiang, J.Z. Zheng, Z. Lu, T. Hunter, and P.K. Vogt Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1 Cell Growth Differ 12 7 2001 363 369
68. Y.J. Jung, J.S. Isaacs, S. Lee, J. Trepel, and L. Neckers IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J 17 14 2003 2115 2117
69. S. Kaluz, M. Kaluzova, and E.J. Stanbridge Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain Mol Cell Biol 26 15 2006 5895 5907
70. S. Kawano, W. Ikeda, M. Kishimoto, H. Ogita, and Y. Takai Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2 J Biol Chem 284 35 2009 23793 23805
71. A.A. Kazi, R.A. Gilani, A.J. Schech, S. Chumsri, G. Sabnis, and P. Shah Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer Breast Cancer Res 16 1 2014 R15
72. K.W. Kim, S.K. Bae, O.H. Lee, M.H. Bae, M.J. Lee, and B.C. Park Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma Cancer Res 58 2 1998 348 351
73. I. Komsuoglu Celikyurt, T. Utkan, C. Ozer, N. Gacar, and F. Aricioglu Effects of YC-1 on learning and memory functions of aged rats Med Sci Monit Basic Res 20 2014 130 137
74. A.C. Koong, N.C. Denko, K.M. Hudson, C. Schindler, L. Swiersz, and C. Koch Candidate genes for the hypoxic tumor phenotype Cancer Res 60 4 2000 883 887
75. S. Kummar, M. Raffeld, L. Juwara, Y. Horneffer, A. Strassberger, and D. Allen Multihistology: target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors Clin Cancer Res 17 15 2011 5123 5131
76. P. Lahiry, A. Torkamani, N.J. Schork, and R.A. Hegele Kinase mutations in human disease: interpreting genotype-phenotype relationships Nat Rev Genet 11 1 2010 60 74
77. A. Lal, H. Peters, B. St Croix, Z.A. Haroon, M.W. Dewhirst, and R.L. Strausberg Transcriptional response to hypoxia in human tumors J Natl Cancer Inst 93 17 2001 1337 1343
78. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 12 2001 3995 4004
79. Y.H. Lee, B.L. Morrison, and D.P. Bottaro Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia J Biol Chem 289 30 2014 20448 20461
80. M.A. Lemmon, and J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 141 7 2010 1117 1134
81. S. Leon Carrion, C.H. Sutter, and T.R. Sutter Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation Exp Dermatol 23 3 2014 211 214
82. M.A. Leonis, M.N. Thobe, and S.E. Waltz Ron-receptor tyrosine kinase in tumorigenesis and metastasis Future Oncol 3 4 2007 441 448
83. A.P. Levy, N.S. Levy, and M.A. Goldberg Post-transcriptional regulation of vascular endothelial growth factor by hypoxia J Biol Chem 271 5 1996 2746 2753
84. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv Cancer Res 74 1998 49 139
85. L. Li, and R. Bhatia Stem cell quiescence Clin Cancer Res 17 15 2011 4936 4941
86. Y.M. Li, B.P. Zhou, J. Deng, Y. Pan, N. Hay, and M.C. Hung A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells Cancer Res 65 8 2005 3257 3263
87. Q. Lin, and Z. Yun Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics Cancer Biol Ther 9 12 2010 949 956
88. W.M. Linehan, M.I. Lerman, and B. Zbar Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer JAMA 273 7 1995 564 570
89. R.M. Linger, A.K. Keating, H.S. Earp, and D.K. Graham TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer Adv Cancer Res 100 2008 35 83
90. Y.V. Liu, J.H. Baek, H. Zhang, R. Diez, R.N. Cole, and G.L. Semenza RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha Mol Cell 25 2 2007 207 217
91. P.K. Majumder, P.G. Febbo, R. Bikoff, R. Berger, Q. Xue, and L.M. McMahon mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways Nat Med 10 6 2004 594 601
92. M. Medova, D.M. Aebersold, W. Blank-Liss, B. Streit, M. Medo, and S. Aebi MET inhibition results in DNA breaks and synergistically sensitizes tumor cells to DNA-damaging agents potentially by breaching a damage-induced checkpoint arrest Genes Cancer 1 10 2010 1053 1062
93. M. Medova, D.M. Aebersold, and Y. Zimmer MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks Int J Cancer 130 3 2012 728 734
94. P.S. Meltzer Cancer genomics: small RNAs with big impacts Nature 435 7043 2005 745 746
95. A.M. Mercurio, R.E. Bachelder, R.C. Bates, and J. Chung Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin Semin Cancer Biol 14 2 2004 115 122
96. P. Michieli Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? Cell Cycle 8 20 2009 3291 3296
97. T. Mijatovic, E. Van Quaquebeke, B. Delest, O. Debeir, F. Darro, and R. Kiss Cardiotonic steroids on the road to anti-cancer therapy Biochim Biophys Acta 1776 1 2007 32 57
98. A. Mishra, J. Wang, Y. Shiozawa, S. McGee, J. Kim, and Y. Jung Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer Mol Cancer Res 10 6 2012 703 712
99. Y. Miyazaki, A. Hara, K. Kato, T. Oyama, Y. Yamada, and H. Mori The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma Int J Oncol 32 1 2008 145 151
100. M. Miyazawa, M. Yasuda, M. Fujita, H. Kajiwara, K. Hirabayashi, and S. Takekoshi Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma Pathol Int 59 1 2009 19 27
101. B.J. Moeller, Y. Cao, C.Y. Li, and M.W. Dewhirst Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules Cancer Cell 5 5 2004 429 441
102. K. Momose, A. Minami, Y. Shimono, K. Mizutani, K. Nobutani, and T. Azuma miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling Genes Cells 18 3 2013 195 202
103. D.K. Moscatello, M. Santra, D.M. Mann, D.J. McQuillan, A.J. Wong, and R.V. Iozzo Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor J Clin Investig 101 2 1998 406 412
104. D. Mukhopadhyay, L. Tsiokas, X.M. Zhou, D. Foster, J.S. Brugge, and V.P. Sukhatme Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature 375 6532 1995 577 581
105. G. Multhoff, J. Radons, and P. Vaupel Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance Cancers (Basel) 6 2 2014 813 828
106. Y. Murakami Involvement of a cell adhesion molecule: TSLC1/IGSF4, in human oncogenesis Cancer Sci 96 9 2005 543 552
107. A. Murakami, F. Takahashi, F. Nurwidya, I. Kobayashi, K. Minakata, and M. Hashimoto Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor PLOS ONE 9 1 2014 e86459
108. L. Naldini, L. Tamagnone, E. Vigna, M. Sachs, G. Hartmann, and W. Birchmeier Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor EMBO J 11 13 1992 4825 4833
109. T. Neill, H. Painter, S. Buraschi, R.T. Owens, M.P. Lisanti, and L. Schaefer Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3 J Biol Chem 287 8 2012 5492 5506
110. R.A. Newman, P. Yang, A.D. Pawlus, and K.I. Block Cardiac glycosides as novel cancer therapeutic agents Mol Interv 8 1 2008 36 49
111. M.J. Niederst, and J.A. Engelman Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer Sci Signal 6 294 2013 re6
112. M.B. Nilsson, P.E. Zage, L. Zeng, L. Xu, T. Cascone, and H.K. Wu Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors Oncogene 29 20 2010 2938 2949
113. I. Paatero, A. Jokilammi, P.T. Heikkinen, K. Iljin, O.P. Kallioniemi, and F.E. Jones Interaction with ErbB4 promotes hypoxia-inducible factor-1alpha signaling J Biol Chem 287 13 2012 9659 9671
114. I. Paatero, T.N. Seagroves, K. Vaparanta, W. Han, F.E. Jones, and R.S. Johnson Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland J Biol Chem 289 32 2014 22459 22469
115. I. Paatero, T.N. Seagroves, K. Vaparanta, W. Han, F.E. Jones, and R.S. Johnson Hypoxia-inducible factor-1alpha induces ErbB4 signaling in the differentiating mammary gland J Biol Chem 289 32 2014 22459 22469
116. R.G. Parton, and K. Simons The multiple faces of caveolae Nat Rev Mol Cell Biol 8 3 2007 185 194
117. J. Pastorek, S. Pastorekova, I. Callebaut, J.P. Mornon, V. Zelnik, and R. Opavsky Cloning and characterization of MN: a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment Oncogene 9 10 1994 2877 2888
118. M.K. Paul, and A.K. Mukhopadhyay Tyrosine kinase - role and significance in Cancer Int J Med Sci 1 2 2004 101 115
119. M.D. Pegram, G. Pauletti, and D.J. Slamon HER-2/neu as a predictive marker of response to breast cancer therapy Breast Cancer Res Treat 52 1-3 1998 65 77
120. X.H. Peng, P. Karna, Z. Cao, B.H. Jiang, M. Zhou, and L. Yang Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression J Biol Chem 281 36 2006 25903 25914
121. S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano, and P.M. Comoglio Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 4 2003 347 361
122. A.M. Petit, J. Rak, M.C. Hung, P. Rockwell, N. Goldstein, and B. Fendly Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors Am J Pathol 151 6 1997 1523 1530
123. S.R. Pfeffer Motivating endosome motility Nat Cell Biol 1 6 1999 E145 E147
124. R.J. Phillips, J. Mestas, M. Gharaee-Kermani, M.D. Burdick, A. Sica, and J.A. Belperio Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha J Biol Chem 280 23 2005 22473 22481
125. A.M. Pierce, and A.K. Keating TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system Brain Res 1542 2014 206 220
126. S.J. Pilkis, and D.K. Granner Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis Annu Rev Physiol 54 1992 885 909
127. R.S. Pillai, S.N. Bhattacharyya, and W. Filipowicz Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17 3 2007 118 126
128. N. Pore, Z. Jiang, A. Gupta, G. Cerniglia, G.D. Kao, and A. Maity EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms Cancer Res 66 6 2006 3197 3204
129. M. Prewett, M. Rothman, H. Waksal, M. Feldman, N.H. Bander, and D.J. Hicklin Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice Clin Cancer Res 4 12 1998 2957 2966
130. J.P. Pursiheimo, K. Rantanen, P.T. Heikkinen, T. Johansen, and P.M. Jaakkola Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62 Oncogene 28 3 2009 334 344
131. E.B. Rankin, K.C. Fuh, L. Castellini, K. Viswanathan, E.C. Finger, and A.N. Diep Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET Proc Natl Acad Sci USA 111 37 2014 13373 13378
132. A. Rapisarda, B. Uranchimeg, D.A. Scudiero, M. Selby, E.A. Sausville, and R.H. Shoemaker Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway Cancer Res 62 15 2002 4316 4324
133. D.E. Richard, E. Berra, and J. Pouyssegur Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells J Biol Chem 275 35 2000 26765 26771
134. F. Rilke, M.I. Colnaghi, N. Cascinelli, S. Andreola, M.T. Baldini, and R. Bufalino Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors Int J Cancer 49 1 1991 44 49
135. S.A. Rosenzweig Acquired resistance to drugs targeting receptor tyrosine kinases Biochem Pharmacol 83 8 2012 1041 1048
136. K. Ruan, G. Song, and G. Ouyang Role of hypoxia in the hallmarks of human cancer J Cell Biochem 107 6 2009 1053 1062
137. G. Sabnis, and A. Brodie Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance Mol Cell Endocrinol 340 2 2011 142 147
138. S.C. Santos, and S. Dias Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways Blood 103 10 2004 3883 3889
139. M. Santra, I. Eichstetter, and R.V. Iozzo An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells J Biol Chem 275 45 2000 35153 35161
140. L. Schito, S. Rey, M. Tafani, H. Zhang, C.C. Wong, and A. Russo Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells Proc Natl Acad Sci USA 109 40 2012 E2707 E2716
141. P. Schraml, J. Kononen, L. Bubendorf, H. Moch, H. Bissig, and A. Nocito Tissue microarrays for gene amplification surveys in many different tumor types Clin Cancer Res 5 8 1999 1966 1975
142. P. Secades, J.P. Rodrigo, M. Hermsen, C. Alvarez, C. Suarez, and M.D. Chiara Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas Genes Chromosomes Cancer 48 5 2009 441 454
143. P. Secades, I.S. de Santa-María, A. Merlo, C. Suarez, and M.D. Chiara In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: implications for anti-epidermal growth factor receptor therapy Head Neck 2014 10.1002/hed.23733
144. G.L. Semenza Hypoxia-inducible factor 1: master regulator of O2 homeostasis Curr Opin Genet Dev 8 5 1998 588 594
145. G.L. Semenza HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus Cell 107 1 2001 1 3
146. G.L. Semenza Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy Trends Pharmacol Sci 33 4 2012 207 214
147. A. Serra-Pérez, A.M. Planas, A. Núñez-O'Mara, E. Berra, J. García-Villoria, and A. Ribes Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites J Biol Chem 285 24 2010 18217 18224
148. N. Simiantonaki, C. Jayasinghe, R. Michel-Schmidt, K. Peters, M.I. Hermanns, and C.J. Kirkpatrick Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines Int J Oncol 32 3 2008 585 592
149. N. Skuli, S. Monferran, C. Delmas, I. Lajoie-Mazenc, G. Favre, and C. Toulas Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells Cancer Res 66 1 2006 482 489
150. I. Stein, M. Neeman, D. Shweiki, A. Itin, and E. Keshet Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes Mol Cell Biol 15 10 1995 5363 5368
151. H.H. Steiner, S. Karcher, M.M. Mueller, E. Nalbantis, S. Kunze, and C. Herold-Mende Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels J Neurooncol 66 1-2 2004 129 138
152. V. Subbiah, J.C. Trent, and R. Kurzrock Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors J Clin Oncol 28 24 2010 e415
153. H.L. Sun, Y.N. Liu, Y.T. Huang, S.L. Pan, D.Y. Huang, and J.H. Guh YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia Oncogene 26 27 2007 3941 3951
154. H. Sun, G. Li, W. Zhang, Q. Zhou, Y. Yu, and Y. Shi Niacin activates the PI3K/Akt cascade via PKC- and EGFR-transactivation-dependent pathways through hydroxyl-carboxylic acid receptor 2 PLOS ONE 9 11 2014 e112310
155. D.E. Swinson, and K.J. O'Byrne Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer Clin Lung Cancer 7 4 2006 250 256
156. L. Tacchini, P. Dansi, E. Matteucci, and M.A. Desiderio Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells Carcinogenesis 22 9 2001 1363 1371
157. L. Tacchini, C. De Ponti, E. Matteucci, R. Follis, and M.A. Desiderio Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression: implicated in survival, differently in different carcinoma cell lines Carcinogenesis 25 11 2004 2089 2100
158. M. Takacova, P. Bullova, V. Simko, L. Skvarkova, M. Poturnajova, and L. Feketeova Expression pattern of carbonic anhydrase IX in medullary thyroid carcinoma supports a role for RET-mediated activation of the HIF pathway Am J Pathol 184 4 2014 953 965
159. H. Takagi, G.L. King, G.S. Robinson, N. Ferrara, and L.P. Aiello Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells Investig Ophthalmol Vis Sci 37 11 1996 2165 2176
160. K. Takeuchi, and F. Ito Receptor tyrosine kinases and targeted cancer therapeutics Biol Pharm Bull 34 12 2011 1774 1780
161. N. Tang, L. Wang, J. Esko, F.J. Giordano, Y. Huang, and H.P. Gerber Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis Cancer Cell 6 5 2004 485 495
162. C.M. Teng, C.C. Wu, F.N. Ko, F.Y. Lee, and S.C. Kuo YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice Eur J Pharmacol 320 2-3 1997 161 166
163. X. Teng, D. Li, and R.A. Johns Hypoxia up-regulates mouse vascular endothelial growth factor D promoter activity in rat pulmonary microvascular smooth-muscle cells Chest 121 3 Suppl. 2002 82S 83S
164. A. Thangasamy, J. Rogge, and S. Ammanamanchi Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells J Biol Chem 284 21 2009 14001 14010
165. C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G.L. Semenza, and E. Van Obberghen Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway J Biol Chem 277 31 2002 27975 27981
166. A. Trumpp, and O.D. Wiestler Mechanisms of disease: cancer stem cells - targeting the evil twin Nat Clin Pract Oncol 5 6 2008 337 347
167. E. Tzahar, and Y. Yarden The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands Biochim Biophys Acta 1377 1 1998 M25 M37
168. A. Ullrich, and J. Schlessinger Signal transduction by receptors with tyrosine kinase activity Cell 61 2 1990 203 212
169. S. Unwith The potential role of HIF on tumour progression and dissemination Int J Cancer 2014 10.1002/ijc.28889
170. P. Valverde Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation Biochem Biophys Res Commun 333 1 2005 180 185
171. P. Vaupel Tumor microenvironmental physiology and its implications for radiation oncology Semin Radiat Oncol 14 3 2004 198 206
172. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 7 2002 489 501
173. X. Wang, and A. Schneider HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia Carcinogenesis 31 7 2010 1202 1210
174. D. Wang, H.J. Huang, A. Kazlauskas, and W.K. Cavenee Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase Cancer Res 59 7 1999 1464 1472
175. E.S. Wang, J. Teruya-Feldstein, Y. Wu, Z. Zhu, D.J. Hicklin, and M.A. Moore Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo Blood 104 9 2004 2893 2902
176. Y. Wang, O. Roche, M.S. Yan, G. Finak, A.J. Evans, and J.L. Metcalf Regulation of endocytosis via the oxygen-sensing pathway Nat Med 15 3 2009 319 324
177. Y. Wang, O. Roche, C. Xu, E.H. Moriyama, P. Heir, and J. Chung Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1 Proc Natl Acad Sci USA 109 13 2012 4892 4897
178. M. Wangpaichitr, N. Savaraj, J. Maher, M. Kurtoglu, and T.J. Lampidis Intrinsically lower AKT: mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-d-glucose under hypoxia in lung cancer cell lines Mol Cancer Ther 7 6 2008 1506 1513
179. J.W. Welsh, D. Mahadevan, R. Ellsworth, L. Cooke, D. Bearss, and B. Stea The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells Radiat Oncol 4 2009 69
180. C.C. Wykoff, C.W. Pugh, P.H. Maxwell, A.L. Harris, and P.J. Ratcliffe Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling Oncogene 19 54 2000 6297 6305
181. C.C. Wykoff, N.J. Beasley, P.H. Watson, K.J. Turner, J. Pastorek, and A. Sibtain Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res 60 24 2000 7075 7083
182. Q. Xu, J. Briggs, S. Park, G. Niu, M. Kortylewski, and S. Zhang Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways Oncogene 24 36 2005 5552 5560
183. L. Xu, M.B. Nilsson, P. Saintigny, T. Cascone, M.H. Herynk, and Z. Du Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells Oncogene 29 18 2010 2616 2627
184. K. Yamagata, M. Tagami, K. Ikeda, S. Tsumagari, Y. Yamori, and Y. Nara Differential regulation of glial cell line-derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke-prone spontaneously hypertensive rats Glia 37 1 2002 1 7
185. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2 2001 127 137
186. L. Yen, X.L. You, A.E. Al Moustafa, G. Batist, N.E. Hynes, and S. Mader Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene 19 31 2000 3460 3469
187. E.J. Yeo, Y.S. Chun, Y.S. Cho, J. Kim, J.C. Lee, and M.S. Kim YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1 J Natl Cancer Inst 95 7 2003 516 525
188. C. Yi-fan, and F. Li-wu Mechanisms of acquired resistance to tyrosine kinase inhibitors Acta Pharm Sin B 1 4 2011 197 207
189. D. Yoshida, K. Kim, M. Noha, and A. Teramoto Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells J Neurooncol 76 1 2006 13 21
190. E. Zelzer, Y. Levy, C. Kahana, B.Z. Shilo, M. Rubinstein, and B. Cohen Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT EMBO J 17 17 1998 5085 5094
191. L. Zhang, W. Zhou, V.E. Velculescu, S.E. Kern, R.H. Hruban, and S.R. Hamilton Gene expression profiles in normal and cancer cells Science 276 5316 1997 1268 1272
192. H. Zhang, D.Z. Qian, Y.S. Tan, K. Lee, P. Gao, and Y.R. Ren Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth Proc Natl Acad Sci USA 105 50 2008 19579 19586
193. H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, and M.M. Georgescu Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res 60 6 2000 1541 1545